Institutional support is crucial for stock performance. IBD's rating system measures price movement on a scale of 1 to 99. Stocks with RS Rating of 80 or higher in early stages tend to perform well. Analyze Sarepta Therapeutics' price strength and growth potential.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing